☆ 4.6 Letter

Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients

BLOOD ADVANCES (2023)

Related references

Note: Only part of the references are listed.

Letter Hematology

Interferon-γ blockade in CAR T-cell therapy-associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis

Michael Rainone et al.

BLOOD ADVANCES (2023)

Add to Collection

Article Oncology

Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic Malignancies

Stefanie R. Bailey et al.

Summary: Blocking IFN gamma in CAR T cells does not impair their cytotoxicity against hematologic tumor cells and paradoxically enhances their proliferation and reduces macrophage-mediated cytokines and chemokines associated with CRS. These findings suggest that IFN gamma blockade may improve CAR T-cell function while reducing treatment-related toxicity in hematologic malignancies.

BLOOD CANCER DISCOVERY (2022)

Add to Collection

Review Oncology

The role of interferon-gamma and its signaling pathway in pediatric hematological disorders

Pietro Merli et al.

Summary: IFN-γ plays a key role in HLH and AA, and inhibiting it has therapeutic potential, with approved treatments available. Further research is needed to explore the efficacy of IFN-γ inhibition, especially in controlling hyperinflammation due to CAR T cells.

PEDIATRIC BLOOD & CANCER (2021)

Add to Collection

Letter Oncology

Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective

Michael P. Triebwasser et al.

PEDIATRIC BLOOD & CANCER (2021)

Add to Collection

Article Immunology

Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy

Nicholas J. Gloude et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

F. Locatelli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Meeting Abstract Hematology

Population Pharmacokinetic Analysis of Emapalumab, a Fully Human, Anti-Interferon Gamma Monoclonal Antibody, in Children with Primary Hemophagocytic Lymphohistiocytosis

Christian Laveille et al.

BLOOD (2020)

Add to Collection

Meeting Abstract Rheumatology

EMAPALUMAB (ANTI-INTERFERON-GAMMA MONOCLONAL ANTIBODY) IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)

F. De Benedetti et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

Add to Collection

Article Computer Science, Interdisciplinary Applications

The REDCap consortium: Building an international community of software platform partners

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2019)

Add to Collection

Article Hematology

Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis

Mounica Vallurupalli et al.

BLOOD (2019)

Add to Collection

Article Oncology

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

David T. Teachey et al.

CANCER DISCOVERY (2016)

Add to Collection

Article Computer Science, Interdisciplinary Applications

Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2009)

Add to Collection

Review Cell Biology

Interferon-γ:: an overview of signals, mechanisms and functions

K Schroder et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.